Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy

Table 2

Characteristics of patients included in Canaloxa study between April 2016 and March 2017 in the Oncology department of Groupe Hospitalier Paris Saint Joseph (GHPSJ).

	Patients
	n	()
Gender
Woman	18	50
Man	18	50
Age (years)
< 50	4	11 .11
50-60[	6	16.66
60-70[	14	38.88
> 70	12	33.33
Location of the tumor
Colon	12	33.33
Stomach	6	16.66
Liver	1	2.77
Pancreas	9	25
Rectum	7	19.44
Peritoneum	1	2.77
Cancer Stage
I	0	0
II	1	2.77
III	15	41.66
IV	20	55.55
Chemotherapy protocol
FOLFOX	26	72.22
FOLFIRINOX	9	25
GEMOX	1	2.77
Grade of neuropathy according to NCI-CTCAE v4.0
I	33	91.66
II	3	8.33